What is ICLR's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 14.31B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for ICLR?

P/E (TTM) is 205.86 and 52-week range is $66.57 to $203.91 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s ICLR figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for ICLR?

The company profile lists revenue (TTM) near $8.31B, net income (TTM) near $6.89B, EPS (TTM) near $0.90 when available from the market-data feed. Figures are informational and may lag live markets.

Where is ICON PLC based, and what identifiers does Chartloom list?

The company context section lists headquarters in Dublin, Dublin, IE, 77.2M shares outstanding, ISIN IE0005711209 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

ICON PLC

$ICLR

Health Care · Life Sciences Tools & Services

IR Run Scenarios

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Employees

39,800

Website

www.iconplc.com/

IPO

1998-05-15

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)

Net income (TTM)

EPS (TTM)

P/E (price / listing EPS)

P/S (TTM)

Forward P/E

Forward P/S

EV / EBITDA

PEG (TTM)

FCF yield (TTM)

Gross margin (TTM)

Net margin (TTM)

Forward revenue growth (NTM)

Dividend / share (TTM)

Dividend yield (TTM)

Payout ratio (TTM)

Dividend growth (5Y)

Company context

Exchange

NASDAQ NMS - GLOBAL MARKET

ISIN

IE0005711209

Headquarters

Dublin, Dublin, IE

Shares outstanding

77.2M

NAICS sector

Professional, Scientific, and Technical Services

Institutional ownership

108.21%

Browse other companiesFree AI scores and summaries for more stocks